3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Classical hematology
1
Conditions
Breast Neoplasms
10
Colorectal Neoplasms
5
Ovarian Neoplasms
4
Endometrial Neoplasms
4
Colorectal Neoplasms, Hereditary Nonpolyposis
4
Prostatic Neoplasms
3
Rectal Neoplasms
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Colonic Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8
1
Wilms Tumor
1
Pyloric Stenosis, Hypertrophic
1
Primary Ovarian Insufficiency
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Neurofibromatosis 1
1
Neoplastic Syndromes, Hereditary
1
Neoplasms, Unknown Primary
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Lipodystrophy, Familial Partial
1
Leukemia, Myeloid, Acute
1
Histiocytosis, Non-Langerhans-Cell
1
Histiocytosis, Langerhans-Cell
1
Hepatic Veno-Occlusive Disease
1
Hematopoietic and Lymphatic System Neoplasm
1
Interventions
Voriconazole
1
Traumeel S
1
Therapeutics
1
Stem Cell Transplantation
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Pentetic Acid
1
Minocycline
1
Melphalan
1
Lithium Carbonate
1
Lithium
1
Itraconazole
1
Heparin
1
Hematologic Tests
1
Genetic Testing
1
Genes, p53
1
Gelclair
1
Caspofungin
1
Busulfan
1
Blood Component Removal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Wilms Tumor
×
Genetic Testing
×
Clear all
NCT04168788
2019-11-19
MVO
University Hospital, Angers
Phase NA
Unknown
150 enrolled